Literature DB >> 24238873

Genotype to phenotype via network analysis.

Hannah Carter1, Matan Hofree, Trey Ideker.   

Abstract

A prime objective of genomic medicine is the identification of disease-causing mutations and the mechanisms by which such events result in disease. As most disease phenotypes arise not from single genes and proteins but from a complex network of molecular interactions, a priori knowledge about the molecular network serves as a framework for biological inference and data mining. Here we review recent developments at the interface of biological networks and mutation analysis. We examine how mutations may be treated as a perturbation of the molecular interaction network and what insights may be gained from taking this perspective. We review work that aims to transform static networks into rich context-dependent networks and recent attempts to integrate non-coding RNAs into such analysis. Finally, we conclude with an overview of the many challenges and opportunities that lie ahead.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24238873      PMCID: PMC3866044          DOI: 10.1016/j.gde.2013.10.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  95 in total

Review 1.  Human diseases through the lens of network biology.

Authors:  Laura I Furlong
Journal:  Trends Genet       Date:  2012-12-07       Impact factor: 11.639

Review 2.  Allo-network drugs: extension of the allosteric drug concept to protein- protein interaction and signaling networks.

Authors:  András Szilágyi; Ruth Nussinov; Péter Csermely
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  Interactome3D: adding structural details to protein networks.

Authors:  Roberto Mosca; Arnaud Céol; Patrick Aloy
Journal:  Nat Methods       Date:  2012-12-16       Impact factor: 28.547

4.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Authors:  Da Yang; Yan Sun; Limei Hu; Hong Zheng; Ping Ji; Chad V Pecot; Yanrui Zhao; Sheila Reynolds; Hanyin Cheng; Rajesha Rupaimoole; David Cogdell; Matti Nykter; Russell Broaddus; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Jinsong Liu; Ilya Shmulevich; Anil K Sood; Kexin Chen; Wei Zhang
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

Review 5.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

6.  A gene ontology inferred from molecular networks.

Authors:  Janusz Dutkowski; Michael Kramer; Michal A Surma; Rama Balakrishnan; J Michael Cherry; Nevan J Krogan; Trey Ideker
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908

Review 7.  From systems to structure: bridging networks and mechanism.

Authors:  James S Fraser; John D Gross; Nevan J Krogan
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

8.  A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility.

Authors:  Michael C Bassik; Martin Kampmann; Robert Jan Lebbink; Shuyi Wang; Marco Y Hein; Ina Poser; Jimena Weibezahn; Max A Horlbeck; Siyuan Chen; Matthias Mann; Anthony A Hyman; Emily M Leproust; Michael T McManus; Jonathan S Weissman
Journal:  Cell       Date:  2013-02-08       Impact factor: 41.582

9.  Interpretation of genomic variants using a unified biological network approach.

Authors:  Ekta Khurana; Yao Fu; Jieming Chen; Mark Gerstein
Journal:  PLoS Comput Biol       Date:  2013-03-07       Impact factor: 4.475

10.  Human disease-associated genetic variation impacts large intergenic non-coding RNA expression.

Authors:  Vinod Kumar; Harm-Jan Westra; Juha Karjalainen; Daria V Zhernakova; Tõnu Esko; Barbara Hrdlickova; Rodrigo Almeida; Alexandra Zhernakova; Eva Reinmaa; Urmo Võsa; Marten H Hofker; Rudolf S N Fehrmann; Jingyuan Fu; Sebo Withoff; Andres Metspalu; Lude Franke; Cisca Wijmenga
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917

View more
  50 in total

Review 1.  Comparative mapping of host-pathogen protein-protein interactions.

Authors:  Priya S Shah; Jason A Wojcechowskyj; Manon Eckhardt; Nevan J Krogan
Journal:  Curr Opin Microbiol       Date:  2015-08-10       Impact factor: 7.934

Review 2.  Proteomic and interactomic insights into the molecular basis of cell functional diversity.

Authors:  Isabell Bludau; Ruedi Aebersold
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-31       Impact factor: 94.444

Review 3.  Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.

Authors:  Neelroop N Parikshak; Michael J Gandal; Daniel H Geschwind
Journal:  Nat Rev Genet       Date:  2015-07-07       Impact factor: 53.242

Review 4.  Functional genomics links genetic origins to pathophysiology in neurodegenerative and neuropsychiatric disease.

Authors:  Brie Wamsley; Daniel H Geschwind
Journal:  Curr Opin Genet Dev       Date:  2020-07-04       Impact factor: 5.578

5.  Function-driven discovery of disease genes in zebrafish using an integrated genomics big data resource.

Authors:  Hongseok Shim; Ji Hyun Kim; Chan Yeong Kim; Sohyun Hwang; Hyojin Kim; Sunmo Yang; Ji Eun Lee; Insuk Lee
Journal:  Nucleic Acids Res       Date:  2016-10-05       Impact factor: 16.971

6.  A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine.

Authors:  Andrew M Stern; Mark E Schurdak; Ivet Bahar; Jeremy M Berg; D Lansing Taylor
Journal:  J Biomol Screen       Date:  2016-03-08

Review 7.  Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations.

Authors:  Lang Wu; Daniel J Schaid; Hugues Sicotte; Eric D Wieben; Hu Li; Gloria M Petersen
Journal:  J Med Genet       Date:  2014-11-04       Impact factor: 6.318

8.  Systems biology and the analysis of genetic variation.

Authors:  Shamil R Sunyaev; Frederick P Roth
Journal:  Curr Opin Genet Dev       Date:  2013-11-28       Impact factor: 5.578

Review 9.  Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.

Authors:  Kaixin Zhou; Helle Krogh Pedersen; Adem Y Dawed; Ewan R Pearson
Journal:  Nat Rev Endocrinol       Date:  2016-04-11       Impact factor: 43.330

10.  Systematic Evaluation of Molecular Networks for Discovery of Disease Genes.

Authors:  Justin K Huang; Daniel E Carlin; Michael Ku Yu; Wei Zhang; Jason F Kreisberg; Pablo Tamayo; Trey Ideker
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.